![]() Pacific Biosciences of California Pacific Biosciences of California (PacBio, formerly known as Nanofluidics) is a company developing a platform for genetic analysis. | ![]() Thermo Fisher Scientific Thermo Fisher Scientific is a biotechnology company engaged in service science. | ![]() Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | ![]() Roche Roche Holding is a biotech company that providesin-vitro diagnostics and supplies solutions across various disease areas. | BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. | |||
Founding Date | Founding Date 2004 | Founding Date 1956 | Founding Date 1984 | Founding Date 2005 | Founding Date 1998 | Founding Date 2011 | Founding Date 1896 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Menlo Park, US HQ Shanghai, CN Yokohama, JP Seoul, KR Singapore, SG London, GB Baltimore, US see more | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | Locations Tegelen, NL HQ Clayton, AU Antwerpen, BE São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN see more | Locations San Diego, US HQ Melbourne, AU Sao Paulo, BR Beijing, CN Shanghai, CN Évry, FR Berlin, DE see more | Locations Menlo Park, US HQ Shanghai, CN West Wickham, GB | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more | ||
Employees | Employees 72877% increase | Employees 130,000 | Employees 6,0002% decrease | Employees 1,04949% increase | Employees 10,20012% increase | Employees 32538% increase | Employees 103,613 | Employees 4,448 |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) 191.7 b | Valuation ($) 9.4 b | Valuation ($) 2.1 b | Valuation ($) 16.2 b | Valuation ($) 77 m | Valuation ($) N/A | Valuation ($) 3 b |
Twitter followers | Twitter followers 44.6 k | Twitter followers 66.5 k | Twitter followers 16.6 k | Twitter followers 62.3 k | Twitter followers 100.4 k | Twitter followers 3 k | Twitter followers 247.2 k | Twitter followers 131.2 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 98 | Number of tweets (last 30 days) 24 | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 106 | Number of tweets (last 30 days) 20 | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 33 | Number of tweets (last 30 days) 34 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.3 | Average likes per tweet (last 30 days) 8.5 | Average likes per tweet (last 30 days) 0.9 | Average likes per tweet (last 30 days) 7.5 | Average likes per tweet (last 30 days) 3.5 | Average likes per tweet (last 30 days) 1.5 | Average likes per tweet (last 30 days) 9.8 | Average likes per tweet (last 30 days) 71.7 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 91.67% | Percentage of tweets with engagement (last 30 days) 70% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 75% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 84.85% | Percentage of tweets with engagement (last 30 days) 82.35% |
Employee Rating | Employee Rating 3.4 | Employee Rating 3.8 | Employee Rating 3.8 | Employee Rating 3.6 | Employee Rating 4.1 | Employee Rating 3.7 | Employee Rating 4.2 | Employee Rating 3 |
Financial | ||||||||
Revenue (est.) | Revenue (est.) $128.3m (FY, 2022) | Revenue (est.) $44.9b (FY, 2022) | Revenue (est.) $2.1b (FY, 2022) | Revenue (est.) £198.6m (FY, 2022) | Revenue (est.) $4.6b (FY, 2022) | Revenue (est.) $65m (FY, 2022) | Revenue (est.) CHF63.3b (FY, 2022) | Revenue (est.) ¥7b (FY, 2022) |
Cost of goods | Cost of goods $79.3m (FY, 2022) | Cost of goods $25.9b (FY, 2022) | Cost of goods $492.3m (FY, 2022) | Cost of goods £54.4m (FY, 2022) | Cost of goods $1.6b (FY, 2022) | Cost of goods $51.7m (FY, 2022) | Cost of goods CHF15.3b (FY, 2022) | Cost of goods ¥3.4b (FY, 2022) |
Gross profit | Gross profit $49m (FY, 2022) | Gross profit $19b (FY, 2022) | Gross profit $1.7b (FY, 2022) | Gross profit £144.3m (FY, 2022) | Gross profit $3b (FY, 2022) | Gross profit $13.4m (FY, 2022) | Gross profit CHF51.1b (FY, 2022) | Gross profit ¥3.7b (FY, 2022) |
Net income | Net income ($314.2m) (FY, 2022) | Net income $7b (FY, 2022) | Net income $575.7m (FY, 2022) | Net income (£91m) (FY, 2022) | Net income ($4.4b) (FY, 2022) | Net income ($113.3m) (FY, 2022) | Net income CHF13.5b (FY, 2022) | Net income ¥809.4m (FY, 2022) |
Operating ⚠ | ||||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 120 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A | Countries 100 (FY, 2022) |
Customers | Customers N/A | Customers 400 k (FY, 2020) | Customers 500 k (FY, 2022) | Customers N/A | Customers N/A | Customers N/A | Customers N/A | Customers N/A |
Patents (US) | Patents (US) 221 (FY, 2016) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 1.2 k (FY, 2022) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations $26.8b (Q3, 2023) | Remaining Performance Obligations $54.5m (FY, 2022) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A |
Funding | ||||||||
Total funding raised | Total funding raised $ 513.6m | Total funding raised $ 500m | Total funding raised $ 4m | Total funding raised $ 1.3b | Total funding raised $ 28m | Total funding raised $ 75m | Total funding raised $ 7.8b | Total funding raised N/A |
Thermo Fisher Scientific is a biotechnology company engaged in service science.
View companyQiagen is a company that provides sample and assay technologies for molecular testing.
View companyOxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules.
View companyIllumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company